Clinical Trial

A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple Sclerosis

Name: A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple Sclerosis — clinical trial record (NCT07749157)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NOVA-BEAM

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and, pharmacodynamics (PD) of subcutaneously administered RO7845860 in participants with relapsing multiple sclerosis (RMS).

Trial Details

NCT Number	NCT07749157
Lead Sponsor	Hoffmann-La Roche
Conditions	Relapsing Multiple Sclerosis
Enrollment	85 participants
Start Date	2026-11-23
Primary Completion	2031-02-28 (estimated)
Study Completion	2031-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-08-06